- Acute spinal cord injury (SCI), a sudden traumatic damage to the spinal cord, is a critical medical emergency that demands prompt intervention and continues to represent a significant burden on healthcare systems worldwide due to its debilitating nature and long-term care requirements
- The escalating demand for acute SCI treatment is primarily fueled by the growing incidence of road traffic accidents, sports injuries, falls in the elderly population, and increasing awareness around early diagnosis and rehabilitation interventions
- North America dominated the acute spinal cord injury market with the largest revenue share of 42.2% in 2024, driven by advanced trauma care infrastructure, robust healthcare spending, and ongoing clinical research focused on neuroregeneration and functional recovery
- Asia-Pacific is expected to be the fastest growing region in the acute spinal cord injury market during the forecast period due to improving healthcare access, higher patient volumes, and increasing investments in medical infrastructure and trauma centers
- The corticosteroids segment dominated the acute SCI treatment market with a market share of 40% in 2024, attributed to its established role in managing inflammation and minimizing secondary injury in the early stages following trauma
